ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,938.70
1.64%
US Tech 100
20,634.40
2.13%
Dow Jones
43,183.32
1.56%
Brent Oil
80.17
0.59%
Bitcoin
99,127.89
2.72%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Advicenne (ALDVI) Quote

Advicenne

Advicenne (ALDVI)

EU
2.015
0.027
( 1.36% )
Updated: 09:58:30
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.015
Bid
2.015
Ask
2.02
Volume
13,566
1.968 Day's Range 2.04
0.827 52 Week Range 3.06
Market Cap
20.016M
Previous Close
1.988
Open
1.99
Last Trade
12
@
2.015
Last Trade Time
09:58:31
Financial Volume
-
VWAP
-
Average Volume (3m)
26,187
Shares Outstanding
9,933,732
Dividend Yield
-
PE Ratio
-2.84
Earnings Per Share (EPS)
-0.71
Revenue
3.48M
Net Profit
-7.03M

About Advicenne

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.advicenne.com
Headquarters
Paris, Paris, Fra
Founded
-
Advicenne is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALDVI. The last closing price for Advicenne was 1.99 €. Over the last year, Advicenne shares have traded in a share price range of 0.827 € to 3.06 €.

Advicenne currently has 9,933,732 shares outstanding. The market capitalization of Advicenne is 19.75 € million. Advicenne has a price to earnings ratio (PE ratio) of -2.84.

Ask ADVFN Intelligence (AI)

ALDVI Latest News

More News

Advicenne Announces its 2025 Financial Calendar

Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those...

November 28 2024
Business Wire

FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.

 After distal Renal Tubular Acidosis (dRTA) in December 2022, ADV7103 is granted "orphan drug" status in the United States in cystinuria. A long-awaited milestone for the Company and its...

March 25 2024
Business Wire

Advicenne annonce les résultats de son augmentation de capital avec maintien du droit préférentiel de souscription

Souscription à hauteur de 5,7 M€ représentant 95% du montant initial Cemag Invest et Bpifrance détiennent respectivement 18,0% et 21,6% du capital et 17,6% et 23,6% des droits de vote  ...

October 02 2023
Business Wire

Advicenne : Lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription afin d’accélérer la croissance en Europe et d’optimiser le développement clinique de ADV7103

Augmentation de capital avec maintien du droit préférentiel de souscription (le “DPS”) d’un montant initial de 6,0 M€, pouvant être porté à 6,9 M€ en cas d’exercice intégral de la clause...

September 11 2023
Business Wire

Advicenne annonce le lancement de Sibnayal® au Danemark

Sibnayal® (citrate de potassium / bicarbonate de potassium) commercialisé depuis le 1er Mars 2023 Le prix de référence correspond à un coût de traitement annuel de 15.000 euros par patient...

March 06 2023
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.125-5.841121495332.142.21.968265472.0145771DE
40.34520.65868263471.672.21.55289151.95085349DE
120.1156.052631578951.92.251.55261871.98194135DE
26-0.02-0.9828009828012.0352.390.827444391.63425657DE
52-0.535-20.98039215692.553.060.827466931.81148582DE
156-4.485-696.56.80.827284222.73322529DE
260-4.485-696.56.80.827284222.73322529DE

ALDVI - Frequently Asked Questions (FAQ)

What is the current Advicenne share price?
The current share price of Advicenne is 2.015 €
How many Advicenne shares are in issue?
Advicenne has 9,933,732 shares in issue
What is the market cap of Advicenne?
The market capitalisation of Advicenne is EUR 19.75M
What is the 1 year trading range for Advicenne share price?
Advicenne has traded in the range of 0.827 € to 3.06 € during the past year
What is the PE ratio of Advicenne?
The price to earnings ratio of Advicenne is -2.84
What is the cash to sales ratio of Advicenne?
The cash to sales ratio of Advicenne is 5.73
What is the reporting currency for Advicenne?
Advicenne reports financial results in EUR
What is the latest annual turnover for Advicenne?
The latest annual turnover of Advicenne is EUR 3.48M
What is the latest annual profit for Advicenne?
The latest annual profit of Advicenne is EUR -7.03M
What is the registered address of Advicenne?
The registered address for Advicenne is 262, RUE DU FAUBOURG, PARIS, PARIS, 75008
What is the Advicenne website address?
The website address for Advicenne is www.advicenne.com
Which industry sector does Advicenne operate in?
Advicenne operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GTRDSGroupe Tera DS
0.0045 €
(200.00%)
296
ALCYBCybergun
0.0002 €
(100.00%)
23.16M
HYPDSHipay Group DS
0.02 €
(61.29%)
5.01k
MLEFAEduformAction
0.396 €
(21.47%)
4.2k
ALVERVergnet
0.0019 €
(18.75%)
195.38M
ALDVAlliance Developpement Capital Siic
0.0555 €
(-25.00%)
620.21k
ALBOOBOOSTHEAT
0.0798 €
(-21.76%)
59.57k
ALLPLLepermislibre SA
0.402 €
(-18.79%)
6.49k
ALMETMethanor
2.02 €
(-14.04%)
2.11k
AAAAlan Allman Associates
7.00 €
(-13.58%)
2.1k
ATOAtos SE
0.0022 €
(4.76%)
696.01M
ALVERVergnet
0.0019 €
(18.75%)
195.38M
BCPBanco Comercial Portugues SA
0.4888 €
(1.20%)
65.03M
ALCYBCybergun
0.0002 €
(100.00%)
23.16M
ALADOAdomos
0.0002 €
(0.00%)
11.84M

Discussion

View Full Feed
gimmegimmeminemine gimmegimmeminemine 1 minute ago
What do you expect and how can you back your thoughts? Thanks
It's hard to calculate accurately as we don't have enough details to go off of.

First you would have to know how much they have on hand now.

Kim told us they created 1200lbs of cocoons.
Using th
KBLB
Chartmaster Chartmaster 2 minutes ago
With the addition of 13 new Hilton locations and the strategic capabilities offered by ChargeTronix's advanced technology, Green Rain Solar is poised to revolutionize the EV charging landscape, further cementing its position as a leader in urban renewable energy solutions.
NWPN
jhdf51 jhdf51 2 minutes ago
Pretty big claim, I hope he’s right.

JHD
COOP
uranium-pinto-beans uranium-pinto-beans 2 minutes ago
Fed's Barkin said today's CPI suggests inflation is still declining
Fed's Barkin said today's CPI suggests inflation is still declining toward the 2% target. But, there is still work to be done and he still believes policy should remain restrictive. He added he can see paths where prices cont
Sammy boy Sammy boy 2 minutes ago
Well I was 2 days too early on my prediction of a .73 drop. You guys should know the cards by now
FMCC
exwannabe exwannabe 2 minutes ago
No, Advent has a sublease on the GMPO approved portion of the facility that lasts as long as NWBO has the master lease. This is clearly described in the https://www.sec.gov/ix?doc=/Archives/edgar/data/1072379/000141057824000133/nwbo-20231231x10k.htm sublease contract on Edgar . That contract speci
NWBO
pos_stock_hoarder pos_stock_hoarder 2 minutes ago
Same as it ever was with the swamp creatures.
DiscoverGold DiscoverGold 2 minutes ago
$SPY 1hr If we are able to clear our recent high, this will flip the weekly BX...
By: Peter DiCarlo | January 15, 2025

• $SPY 1hr

CPI came in and $SPY +1.70%

We have rejected on this trend level four time.

If we are able to cl
SPY
firebag1 firebag1 2 minutes ago
yeah ive done it we all did it....twice last week i sold a position...they next day it went up, Monday i sold a position to add here...it went up Tuesday...yeah some call it cursed...i say IMPATIENCE!!!! lol
HMBL
HappyLibrarian HappyLibrarian 2 minutes ago
I’m simply amazed at how long this process has taken. I do not fault NWBO’s management in any way and I applaud them for their creative efforts. I do hold the market maker and their employees fully responsible for the lengthy submittal and approval process.

Which specific aspects of t
NWBO
theorysuit theorysuit 2 minutes ago
https://www.reuters.com/article/markets/northwest-bio-wins-swiss-approval-for-cancer-vaccine-idUSL09620301/

approval in switzerland ring a bell?
NWBO
Debunkinator Debunkinator 2 minutes ago
Anything below 0.001 is a freakin gift here. 😎
ASII
Golden Cross Golden Cross 3 minutes ago
💲 $LUXH LuxUrban Hotels Embraces Innovation and Growth in 2025
https://allcapresearch.com/f/luxurban-hotels-embraces-innovation-and-growth-in-2025
LUXH
JJones65 JJones65 3 minutes ago
The Biden market is ending just like it started and has been throughout. The bears get crushed and the market keeps surging forward. Now let's see how the new market is with the new administration. Historically it's not been very good under the Republicans but let's see.
MITIman007 MITIman007 3 minutes ago
My hunch is that most of retail dumped back in September on that high volume day after the weekend when the offering was posted after hours.  Based on Twitter activity, I think random traders saw the action and bought in trips to flip.  Those guys are gone IMO.  The rest of the shares are likely in
MDCE
Lakota-45 Lakota-45 3 minutes ago
WOW - UP 33.33% , . .
on very light volume - Cheers !!!

~ $WDLF ~
WDLF
Golden Cross Golden Cross 3 minutes ago
$LUXH LuxUrban Hotels Embraces Innovation and Growth in 2025
https://allcapresearch.com/f/luxurban-hotels-embraces-innovation-and-growth-in-2025
LUXH
Iggy_Bot Iggy_Bot 4 minutes ago
Bashing one GS stock and Pumping his other, sad you can't afford to own both or more GS stocks.
GVSI
NoMoDo NoMoDo 4 minutes ago
I think Elon Musk once made that promise... don't do it.
HMBL
familyof5 familyof5 4 minutes ago
Humble Beginnings: .02 MINUTE HUMBLE HISTORY CHRONOLOGY.....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175651464
HMBL
chessmaster315 chessmaster315 4 minutes ago
I think we are basically in agreement here, tho we differ on "how we got there". If you go to a NFL game, people come from almost everywhere to see the game, but fans are fans, no matter where they come from.
Our president elect has written a formal letter, some years ago, that he wants FN
DJT
georgie18 georgie18 4 minutes ago
WNW...40s starting here...🥳

georgie18

Member Level
Re: georgie18 post# 96

Wednesday, January 15, 2025 10:33:40 AM

Post#
97
of 97
WNW...37...Bouncing off the .31 bottom...🥳

georgi
CrashOverride CrashOverride 4 minutes ago
Northwest Biotherapeutics isn't "pumping" their share price. They've said very little beyond milestone PRs and required material disclosures in SEC filings which is standard practice for companies seeking regulatory approval.
NWBO
georgie18 georgie18 4 minutes ago
WNW...40s starting here...🥳

georgie18

Member Level
Re: georgie18 post# 96

Wednesday, January 15, 2025 10:33:40 AM

Post#
97
of 97
WNW...37...Bouncing off the .31 bottom...🥳

georgi

Your Recent History

EU
ALDVI
Advicenne
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads